Brief: Argenx Q1 Total Operating Income At $807.37 Mln
08/05/2025 06:12
May 8 (Reuters) - argenx SE ARGX.BR: Q1 OPERATING EXPENSES USD -668.43 MILLION Q1 NET INCOME USD 169.469 MILLION Q1 BASIC EPS USD 2.78 Q1 TOTAL OPERATING INCOME USD 807.37 MILLION Q1 EPS USD 2.58 REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE PHASE 1 RESULTS FROM ONGOING ARGX-109 STUDY EXPECTED IN SECOND HALF OF 2025 PHASE 1 RESULTS FROM ONGOING ARGX-213 STUDY AND ARGX-121 STUDY EXPECTED IN FIRST HALF OF 2026 FINANCIAL GUIDANCE ON THE COMBINED SELLING, GENERAL AND ADMINISTRATIVE EXPENSES AND RESEARCH AND DEVELOPMENT EXPENSES REMAINS UNCHANGED Source text: ID:nGNE3zbx0G Further company coverage: ARGX.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587 785 110;))
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles